FDA Monthly Preview: Key May Decisions to Watch - Top-Institutions - MDSpire

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

  • By

  • Kathryn Wighton

  • April 29, 2026

  • 4 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Endocrinology
    • Psychiatry

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Psychiatry
    • Endocrinology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Psychiatry
    • Endocrinology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Endocrinology
    • Psychiatry

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Endocrinology
    • Psychiatry

Original Source(s)

FDA Monthly Preview: Key May Decisions to Watch

  • by Kathryn Wighton

  • April 29, 2026

Related Content

Not All Poststroke Cognitive Patterns Plateau

Researchers identify divergent recovery, persistence, and decline patterns across cognitive domains following stroke.

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation

Preop Cognitive Impairment Tied to TKA Delirium

Older patients with documented cognitive impairment also experienced greater postoperative functional decline following elective total knee arthroplasty